Administered at a dose of 2 mg/kg over 5 minutes

Administered at a dose of 1 mg over 5 minutes

Abdominal Pain

Renal Colic

Lidocaine Iv

HYDROmorphone Injection

Emergency Department Visits for Chest Pain and Abdominal Pain: United States, 1999-2008

High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department

High Dose Intravenous Lidocaine vs Hydromorphone for Acute Abdominal Pain in the Emergency Department: A Randomized, Comparative Efficacy Trial

The difference between the pain score at time 0 and 90 minutes

Does the patient require off-protocol medication for additional pain relief? Off-protocol defined as any opiate or NSAID

The difference between the pain score at time 0 and 15 minutes

The difference between the pain score at time 0 and 30 minutes

The difference between the pain score at time 0 and 60 minutes

The difference between the pain score at time 0 and 120 minutes

The difference between the pain score at time 0 and 150 minutes

The difference between the pain score at time 0 and 180 minutes

If the patient were to come to the ED again for the same complaint, would they want the same drug they received?

Are any medications required to control medication side effects, defined as any new symptom after the administration of the study drug.

Yes or no, did the patient have any side effects, defined as any new symptom after the administration of the study drug.

Yes or no, was naloxone required after the patient received the study drug?

Yes or no, did the patients disposition change as a consequence of administration of the study drug?

Yes or no, did the patient have an unplanned return visit to an emergency department resulting in hospital admission?

Yes or no, did the patient suffer a serious adverse event? Defined as death, requiring or prolonging inpatient hospitalization, resulting in persistent or significant disability/incapacity, or is considered a significant medical event by the investigator based off of medical judgement.

Hennepin Healthcare Research Institute

The investigators will measure the cutaneous conductance to chlorine by SUDOSCAN® in all dialysis patients without intradialytic hypotension and to seek a link between the results of this examination and the occurrence of discomfort during hemodialysis sessions.

The investigators will measure the cutaneous conductance to chlorine by SUDOSCAN® in all dialysis patients with intradialytic hypotension and to seek a link between the results of this examination and the occurrence of discomfort during hemodialysis sessions.

Hemodialysis Complication

The additional examination, related to this research protocol, corresponds to a record of cutaneous conductance with chlorine. This recording of 2 min 30 is done thanks to SUDOSCAN® within 30 minutes before the dialysis session (before the "connection" to the dialysis machine) and within 30 minutes after the end of the dialysis with a measurement of the tension blood pressure and heart rate immediately before SUDOSCAN®.

Cutaneous conductance to chlorine by SUDOSCAN

AURA Paris Plaisance

Study of Abnormalities of the Nervous System in the Occurrence of Intradialytic Arterial Hypotension

Study of Abnormalities of the Vegetative Nervous System in the Occurrence of Intradialytic Arterial Hypotension

This outcome is to measure cutaneous conductance to chlorine by SUDOSCAN, 30 minuts before hemodialysis.

This outcome is to measure cutaneous conductance to chlorine by SUDOSCAN, 30 minuts after hemodialysis.

Groupe Hospitalier Paris Saint Joseph

Patients will be classified into 2 groups according to the occurrence of intradialytic hypotension which is defined as a decrease in systolic blood pressure greater than 30 mmHg associated with clinical signs (cramps, abdominal pain, unconsciousness, convulsions). Group 1 corresponds to patients with intradialytic hypotension and group 2 corresponds to patients without intradialytic hypotension. This study aims to measure the cutaneous conductance to chlorine by SUDOSCAN® in all dialysis patients and to seek a link between the results of this examination and the occurrence of discomfort during hemodialysis sessions.

The infected individuals were treated with the standard chloroquine (CQ)+primaquine(PQ) regimen to malaria caused by Plasmodium vivax.
Chloroquine (tablet containing 150mg of base) - it was given on days 0 (10mg/kg), 1 (7.5mg/kg) and 2 (7.5mg/kg). Total dose, 25 mg base/kg.
Primaquine - it was given once a day (0.5 mg/kg) for seven days, starting on day 0 of CQ treatment. Total dose, 3.5mg/kg The medications were administered under direct observation and the patient was monitored for vomiting for 60 minutes.

The infected individuals were initially treated with chloroquine (CQ) alone and the primaquine(PQ) was introduced on day 28.
Chloroquine (tablet containing 150mg of base) - it was given on days 0 (10mg/kg), 1 (7.5mg/kg) and 2 (7.5mg/kg). Total dose, 25 mg base/kg.
Primaquine - it was given once a day (0.5 mg/kg) for seven days, starting on day 28 of CQ treatment. Total dose, 3.5mg/kg.
The medications were administered under direct observation and the patient was monitored for vomiting for 60 minutes.

Malaria, Vivax

10mg/kg on day 0 and 7.5mg/kg on days 1 and 2. Total dose, 25 mg base/kg. Tablet containing 150mg of base.

Chloroquine

0.5 mg/kg once a day, for seven days. Total dose, 3.5mg/kg.

Primaquine

Oswaldo Cruz Foundation

Institute of Biomedical Sciences, University of Sao Paulo

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine (PQ) for the Treatment of Uncomplicated Plasmodium Vivax Infection

danger signs or severe malaria on day 1, 2 or 3 in the presence of parasitaemia OR parasitaemia on day 2 higher than on day 0 OR parasitaemia on day 3 with axillary temperature ≥ 37.5 ºC OR parasitaemia on day 3 ≥ 25% of count on day 0

danger signs or severe malaria in the presence of parasitaemia on any day between day 4 and day 28 OR parasitaemia on any day between day 4 and day 28 with axillary temperature ≥ 37.5 ºC (or history of fever) in patients who did not previously meet any of the criteria of early treatment failure

presence of parasitaemia on any day between day 7 and day 28 with axillary temperature < 37.5 ºC in patients who did not previously meet any of the criteria of early treatment failure or late clinical failure

Any unfavourable and unintended sign (including an abnormal laboratory finding), symptom or disease temporally associated with the use of the study medication, whether or not considered related to the study medication.

Any untoward and unintended responses to a medicinal product related to any dose judged by either the reporting medically qualified professional or the sponsor as having a reasonable suspected causal relationship to the study medication.

University of Sao Paulo

In this group patients receive volemic standard treatment (conventional)

In this group patients receive volemic small treatment (restrictive)

Acute Abdomen

Goals:
arterial pressure mean ≥ 65 mmHg or equal to the pre-operative
diuretic rhythm ≥ 1 ml / Kg / h
venous saturation in vena cava ≥ 70% or mixed venous saturation as Swan Ganz's catheter (SG) ≥ 65%
BE> - 3
Central Venous Pression (PVC) ≥ 8 mmHg; for patients undergoing mechanical ventilation, this limit may be raised to 12-15 mmHg.

Standard fluidic resuscitation.

Goals of the treatment:
arterial pressure mean ≥ 60 mmHg or ≥ 10% less than the preoperative values
diuretic rhythm ≥ 0.5 ml / kg / h
venous saturation in vena cava ≥ 60% or mixed venous saturation ≥ 55% by SG
BE> - 5
PVC goal not necessary
To achieve the therapeutic goals set out above will be executed a volemic fill up to values of PVC ≤ 5 mmHg or at maximum values of 2 mmHg more the incoming If after proper filling the targets aren't yet achieved, the patient will begin infusion of vasoactive drugs following the practice of department. If after 12 hours of admission the water balance will be > 10-15 ml / kg / h an infusion of furosemide should be initiated

Volemic small treatment

Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume

MANAGEMENT OF THE PATIENT WITH ACUTE ABDOMEN SUBMITTED TO URGENT ABDOMINAL SURGERY: a Pilot Randomized Multicentre Study

The purpose of this work is to evaluate the clinical changes determined by a different volemic strategy.

colic/seizures

High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department

Study of Abnormalities of the Nervous System in the Occurrence of Intradialytic Arterial Hypotension

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen